Health Business Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Business Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Alkermes, Inc.
Alkermes’ Corporate Presentation to be Webcast at the Deutsche Bank 34th Annual Health Care Conference
June 5th, 2009
Alkermes, Inc. (NASDAQ: ALKS) announced that its corporate presentation will be webcast live by Deutsche Bank on Monday, May 18, 2009, at 9:20 a.m. ET. The presentation will be webcast from the InterContinental Hotel in Boston and may be accessed under the investor relations tab at www.alkermes.com. The presentation will be archived for 14 days. Alkermes, Inc. is a fully integrated biotechnology company committed to developing innovative medicines to improve patients' lives. Alkermes developed, manufactures and commercializes VIVITROL® for alcohol dependence and manufactures RISPERDAL® CONSTA® for schizophrenia. Alkermes' robust pipeline includes extended-release...
Source: Health Business Week (2009-06-05)
|
